|1.||Han, Chang-Kyun: 3 articles (07/2005 - 01/2004)|
|2.||Kwak, Wie-Jong: 3 articles (07/2005 - 01/2004)|
|3.||Cho, Yong-Baik: 3 articles (07/2005 - 01/2004)|
|4.||Kim, Joo-Hyon: 2 articles (07/2005 - 07/2005)|
|5.||Jung, K: 2 articles (06/2002 - 01/2001)|
|6.||Na, Young-In: 1 article (09/2014)|
|7.||Jun, Jae-Bum: 1 article (09/2014)|
|8.||Yoo, Hunseung: 1 article (09/2014)|
|9.||Choi, Chan-Bum: 1 article (09/2014)|
|10.||Choi, Choong Hyeok: 1 article (09/2014)|
07/01/2005 - "SKI306X was previously found to have cartilage protective effects in the experimental osteoarthritis (OA) model. "
06/01/2002 - "Protective effects of SKI 306X, a natural herbal product extracted from three herbs Clematis mandshurica, Trichosanthes kirilowii, and Prunella vulgaris, on articular cartilage was examined and compared with other osteoarthritis (OA) drugs using in vitro and in vivo models. "
10/03/2005 - "Pharmacological efficacy of SKI 306X protecting osteoarthritis in part may result from the inhibition of apoptosis in chondrocytes by Clematis mandshurica."
01/01/2001 - "This study demonstrated that SKI 306X, a new herbal anti-arthritic agent provided clinical efficacy in patients with osteoarthritis."
01/01/2001 - "A double-blind, controlled study was performed to evaluate the efficacy and safety of SKI 306X with placebo in 96 patients with classical osteoarthritis of the knee. "
11/01/2009 - "However, due to differing HMPs, interventions, comparators, and outcome measures, meta-analysis was restricted to data from studies of three HMPs: topical capsaicin, avocado-soybean unsaponifiables, and the Chinese herbal mixture SKI306X showed benefit in the alleviation of osteoarthritic pain.Several"
05/01/2007 - "The results of this study suggest that SKI306X was generally well tolerated and not inferior to celecoxib in regard to pain relief in these Korean patients with RA."
05/01/2007 - "The aim of this study was to compare the pain relief and tolerability of SKI306X and celecoxib in patients with RA. "
05/01/2007 - "The most frequent drug-related AEs were epigastric pain (9/91 [9.9%]) in the SKI306X group and glutamyltranferase elevation (4/92 [4.3%]) in the celecoxib group. "
05/01/2007 - "An analysis of the change in reported pain intensity as determined by VAS (mm) score between baseline and week 3 (mean [SD], 13.64 [16.62] vs 14.45 [15.89]), and between baseline and week 6 (18.4 [20.8] vs 17.9 [19.1], respectively) suggested that SKI306X was not inferior to celecoxib. "
|4.||Arthralgia (Joint Pain)
05/01/2007 - "Those studies found that SKI306X was associated with an anti-inflammatory and analgesic effect, and that it can delay the destruction of cartilage in rheumatoid arthritis (RA). "
05/01/2007 - "Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial."
|1.||Diclofenac (SR 38)
|6.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)